TABLE 1.6 Summary of Findings: Rankings of Various Vaccine Candidates Based on Their Potential Health Benefits Under a Variety of Assumptions and Resource Constraints
|
High
|
Intermediate
|
Low
|
|
S. pneumoniae
|
Hepatitis B virus
|
Hepatitis A (either candidate)
|
|
Plasmodium spp. (malaria; both monovalent and circumsporozoite protein-based approaches)
|
H. influenzae type b
|
N. meningitidis
|
|
E. coli (either candidate)
|
Yellow fever virus
|
|
Rotavirus (all three candidates)
|
Streptococcus group A
|
Dengue
|
|
S. typhi (Ty21a)
|
S. typhi (an aromatic amino acid-requiring strain)
|
Rabies (live vector virus)
|
|
Shigella spp.
|
M. leprae
|
Japanese encephalitis virus
|
|
|
V. cholerae (either candidate)
|
|
|
|
Respiratory syncytial virus (either candidate)
|
|
|
|
Parainfluenza
|
|
|
|
Rabies (vero cell derived or glycoprotein)
|
|
|
NOTE: Because certain vaccine candidates may enter different categories if other plausible assumptions are adopted, these assignments should not be regarded as definitive.
|
